Lam KS - Search Results

1

Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes.

Lam KS, Chow CC, Tan KC, Ma RC, Kong AP, Tong PC, Tsang MW, Chan TM, Tang SC, Lee KK, So WY, Tomlinson B. Lam KS, et al. Curr Med Res Opin. 2016 Jun;32(6):1097-108. doi: 10.1185/03007995.2016.1161608. Epub 2016 Apr 4. Curr Med Res Opin. 2016. PMID: 26933918

2

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.

Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, Lam KS. Tan KC, et al. Among authors: lam ks, lam ch. J Clin Endocrinol Metab. 2002 Feb;87(2):563-8. doi: 10.1210/jcem.87.2.8249. J Clin Endocrinol Metab. 2002. PMID: 11836286 Clinical Trial.

3

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.

Tan KC, Chow WS, Ai VH, Lam KS. Tan KC, et al. Among authors: lam ks. Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6. doi: 10.1002/dmrr.255. Diabetes Metab Res Rev. 2002. PMID: 11921421 Free article. Clinical Trial.

4

Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.

Tan KC, O K, Chow WS, Ai VH, Siow YL, Lam KS. Tan KC, et al. Among authors: lam ks. Eur J Clin Invest. 2002 May;32(5):328-34. doi: 10.1046/j.1365-2362.2002.00990.x. Eur J Clin Invest. 2002. PMID: 12027872

5

Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Tan KC, et al. Among authors: lam ks. Diabetes Care. 2002 Jun;25(6):1055-9. doi: 10.2337/diacare.25.6.1055. Diabetes Care. 2002. PMID: 12032114

6

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.

Tan KC, Tso AW, Tam SC, Pang RW, Lam KS. Tan KC, et al. Among authors: lam ks. Diabet Med. 2002 Nov;19(11):944-8. doi: 10.1046/j.1464-5491.2002.00823.x. Diabet Med. 2002. PMID: 12421432 Clinical Trial.

7

Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese.

Tso AW, Rong R, Lo CY, Tan KC, Tiu SC, Wat NM, Xu JY, Villablanca A, Larsson C, Teh BT, Lam KS. Tso AW, et al. Among authors: lam ks. Clin Endocrinol (Oxf). 2003 Jul;59(1):129-35. doi: 10.1046/j.1365-2265.2003.01812.x. Clin Endocrinol (Oxf). 2003. PMID: 12807514

8

Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions.

Chen SP, Tan KC, Lam KS. Chen SP, et al. Among authors: lam ks. Atherosclerosis. 2003 Apr;167(2):287-92. doi: 10.1016/s0021-9150(03)00004-2. Atherosclerosis. 2003. PMID: 12818411 Free article.

9

C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.

Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. Tan KC, et al. Among authors: lam ks, lam th. Diabetes Care. 2003 Aug;26(8):2323-8. doi: 10.2337/diacare.26.8.2323. Diabetes Care. 2003. PMID: 12882856

10

Effects of treatment with Sandostatin LAR on small dense LDL and remnant-like lipoproteins in patients with acromegaly.

Tan KC, Pang RW, Tiu SC, Lam KS. Tan KC, et al. Among authors: lam ks. Clin Endocrinol (Oxf). 2003 Nov;59(5):558-64. doi: 10.1046/j.1365-2265.2003.01849.x. Clin Endocrinol (Oxf). 2003. PMID: 14616878 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

983 results

Search Page

Filters